RTA 744 Completed Phase 1 Trials for Gliomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00526812A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas